Status:
COMPLETED
Bacterial Colonization in COPD in View of CAT Under ICS+LABA Therapy
Lead Sponsor:
Far Eastern Memorial Hospital
Conditions:
Bacterial Infections
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
20+ years
Brief Summary
Patients with COPD (chronic obstructive pulmonary disease) suffer from episodes of acute exacerbations leading to additional morbidity and mortality, and also a further decline in lung function. It ha...
Eligibility Criteria
Inclusion
- spirometry showed obstructive ventilatory defect (a ratio of forced expiratory volume in one second (FEV1) to forced vital capacity (FVC) of less than 0.7) and FEV1 less than 80% of predicted value and patients receiving the combination therapy of ICS and LABA
Exclusion
- (1) use of antibiotics or corticosteroids within eight weeks before study entry; (2) pneumoconiosis; (3) apparent inactive tuberculosis fibrosis (fibrosis involved in more than one third of one lung field as determined by chest radiography); and (4) asthma and atopic history.
Key Trial Info
Start Date :
March 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT01819298
Start Date
March 1 2011
End Date
June 1 2012
Last Update
March 27 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Far Eastern Memorial Hospital
New Taipei City, Taiwan, 220